Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

KZR

Kezar Life Sciences (KZR)

Kezar Life Sciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KZR
DateTimeSourceHeadlineSymbolCompany
06/07/20245:59PMBusiness WireKezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:KZRKezar Life Sciences Inc
06/04/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KZRKezar Life Sciences Inc
05/29/20244:01PMBusiness WireKezar Life Sciences to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:KZRKezar Life Sciences Inc
05/09/20244:08PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KZRKezar Life Sciences Inc
05/09/20244:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KZRKezar Life Sciences Inc
05/09/20244:01PMBusiness WireKezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:KZRKezar Life Sciences Inc
05/06/20244:05PMBusiness WireKezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:KZRKezar Life Sciences Inc
04/08/20244:01PMBusiness WireKezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:KZRKezar Life Sciences Inc
03/14/20244:01PMBusiness WireKezar Life Sciences Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business UpdateNASDAQ:KZRKezar Life Sciences Inc
03/08/20244:05PMBusiness WireKezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:KZRKezar Life Sciences Inc
02/28/20244:01PMBusiness WireKezar Life Sciences to Participate in the TD Cowen 44th Annual Health Care ConferenceNASDAQ:KZRKezar Life Sciences Inc
02/26/20246:30PMBusiness WireEverest Medicines and Kezar Life Sciences Receive IND Approval from China NMPA for PALIZADE Trial in Lupus NephritisNASDAQ:KZRKezar Life Sciences Inc
02/14/20246:50AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:KZRKezar Life Sciences Inc
01/17/20245:09PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KZRKezar Life Sciences Inc
01/09/20244:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KZRKezar Life Sciences Inc
01/08/20248:36AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KZRKezar Life Sciences Inc
12/04/20234:28PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KZRKezar Life Sciences Inc
11/21/20234:01PMBusiness WireKezar Life Sciences to Present at the 6th Annual Evercore ISI HealthCONx ConferenceNASDAQ:KZRKezar Life Sciences Inc
11/13/20234:13PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KZRKezar Life Sciences Inc
11/13/20234:01PMBusiness WireKezar Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:KZRKezar Life Sciences Inc
11/09/20234:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KZRKezar Life Sciences Inc
11/03/20234:03PMBusiness WireKezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:KZRKezar Life Sciences Inc
10/27/20234:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KZRKezar Life Sciences Inc
10/09/20235:56PMBusiness WireKezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:KZRKezar Life Sciences Inc
10/03/20234:14PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KZRKezar Life Sciences Inc
10/03/20234:10PMBusiness WireKezar Life Sciences Announces Strategic Restructuring to Prioritize Clinical-Stage Assets and Extend Financial Runway and Appoints Christopher Kirk, Ph.D. as Chief Executive OfficerNASDAQ:KZRKezar Life Sciences Inc
09/20/20238:30PMDow Jones NewsStocks to Watch: FedEx, Kezar Life Sciences, TranscatNASDAQ:KZRKezar Life Sciences Inc
09/20/20236:30PMBusiness WireKezar Life Sciences and Everest Medicines Enter into an Agreement to Develop and Commercialize Zetomipzomib for Lupus Nephritis and other Potential Indications in Greater China, South Korea and Southeast AsiaNASDAQ:KZRKezar Life Sciences Inc
08/31/20234:01PMBusiness WireKezar Life Sciences to Participate in Three Upcoming Investor ConferencesNASDAQ:KZRKezar Life Sciences Inc
08/10/20234:12PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KZRKezar Life Sciences Inc
 Showing the most relevant articles for your search:NASDAQ:KZR